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Abstract
Monocyte chemotactic protein-3 (MCP-3) is a CC chemokine that functions in chemoattraction and activation of
monocytes, T lymphocytes, eosinophils, basophils, natural killer cells and dendritic cells. The activation of the target cells by
MCP-3 is via specific chemokine receptors CCR2 and CCR3, of which CCR2 is shared with MCP-1. MCP-1 and CCR2 have
been implicated in vascular diseases including atherosclerosis and restenosis, that are known to be involved in inflammation
(accumulation of T lymphocytes and monocytes) and smooth muscle cell (SMC) activation (proliferation, migration and
matrix deposition). To investigate a potential role of MCP-3 in vascular injury, the present work examined its mRNA
expression in rat aortic SMCs stimulated with various inflammatory stimuli including LPS, TNF-K, IL-1L, IFN-Q and TGF-
L. A time- and concentration-dependant induction of MCP-3 mRNA in SMCs was observed by means of Northern analysis.
A strikingly similar expression profile was observed for MCP-3 and MCP-1 mRNA in SMCs. Furthermore, MCP-3 mRNA
expression was induced in rat carotid artery after balloon angioplasty. A significant induction in MCP-3 mRNA was
observed in the carotid artery at 6 h (41-fold increase over control, P6 0.001), 1 day (13-fold increase, P6 0.001) and 3 days
(6-fold increase, P6 0.01) after balloon angioplasty as quantitated by reverse transcription and polymerase chain reaction.
These data provide evidence for the cytokine-induced expression of MCP-3 in SMCs and in carotid artery after balloon
angioplasty, suggesting a potential role of MCP-3 in the pathogenesis of restenosis and atherosclerosis. ß 2000 Elsevier
Science B.V. All rights reserved.
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1. Introduction
Monocyte chemotactic protein (MCP)-3 is a mem-
ber of the CC or L-chemokine subfamily that in-
cludes MCP-1, macrophage in£ammatory protein
(MIP)-1 and RANTES. The gene encoding for
MCP-3 has been isolated in various species including
human, mouse and rat [1^3]. The amino acid se-
quence of MCP-3 consists of 97 residues in human
and 95 in mouse and rat, and shares considerable
sequencing identity (s 60% between rodents and hu-
man) or similarity (s 86%) [2,3]. MCP-3 is chemo-
tactic preferentially for monocytes, lymphocytes, eo-
sinophils, basophils, natural killer cells and dendritic
cells [4,5]. The receptors for MCP-3 have been char-
acterized, which include CCR2 and CCR3 [5]. In
particular, CCR2 is known to be shared with
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MCP-1, a chemokine that has been proposed to play
an important role in the establishment and progres-
sion of atherosclerosis since its mRNA and protein
are induced in human atherosclerotic lesions [6,7].
Recently, Boring et al. [8] demonstrated that the se-
lective absence of CCR2 could markedly decrease
atherosclerotic lesions in apoE null mice, suggesting
the active involvement of CCR2 and MCP-1, and
possibly MCP-3, in atherogenesis.
Vascular smooth muscle cell (SMC) is a predom-
inant cell type in atherosclerotic lesions and in neo-
intima after balloon angioplasty [9,10]. SMCs can be
activated and induced for proliferation, migration,
and production of extracellular matrix by various
growth factors and cytokines. SMCs have also been
demonstrated to be involved in in£ammatory reac-
tions in vitro and in vivo (during vascular injury).
SMCs can be induced to produce various in£amma-
tory cytokines (including chemokines) and growth
factors, which in turn can react on T lymphocytes,
macrophages and SMCs. For example, interleukin
(IL)-8 and interferon-inducible protein (IP)-10 have
been demonstrated for their ability of chemokine
production and actions in SMCs for their migration,
proliferation and in£ammatory responses [11,12].
The demonstration of functional expression of che-
mokine receptors (such as CCR1 and CCR2) on hu-
man vascular SMCs [13] further supports the possi-
bility that SMCs can react to chemokines, especially
during vascular injury.
To investigate a potential role of MCP-3 in vascu-
lar pathogenesis, in the present study we examined
the expression of MCP-3 mRNA in cultured rat
aortic smooth muscle cells (RASMCs) in response
to various in£ammatory mediators (e.g., lipopolysac-
charide (LPS) tumor necrosis factor (TNF)-K, IL-1L,
interferon (IFN)-Q and transforming growth factor
(TGF)-L) and growth factors (e.g., platelet-derived
growth factor (PDGF), epidermal growth factor
(EGF), ¢broblast growth factor (FGF)). These fac-
tors are known to play an important role in SMC
activation and in particular during vascular injuries
[9,10,14]. Furthermore, we evaluated MCP-3 mRNA
expression in vascular disease process using a well
characterized animal model of balloon angioplasty
of carotid artery.
2. Materials and methods
2.1. Cell cultures
RASMCs were isolated and cultured as described
in detail previously [15]. Brie£y, RASMCs were iso-
lated from medial explants of the thoracic aorta of
male Sprague^Dawley rats (300^350 g) (Charles Riv-
er, Raleigh, NC) and cultured in Dulbecco’s modi-
¢ed Eagle’s medium (DMEM) (Gibco, Grand Island,
NY) supplemented with 10% fetal bovine serum
(FBS) and gentamicin (50 Wg/ml). SMCs were al-
lowed to grow out from the tissue which was con-
sequently removed. After con£uence was reached,
cells were harvested by brief trypsination and subcul-
tured in T-75 £asks. The purity of SMCs was eval-
uated by staining the cells with monoclonal antibod-
ies to SMC K-actin (from hybridoma cells, clone
asm-1; Boehringer Mannheim) [15]. More than
96% of cells exhibited immunoreactivity for SMC
K-actin. RASMC under 6 passages was used in the
present study.
RASMCs were cultured in T-150 £asks, grown to
con£uence and serum-deprived for 48 h, then stimu-
lated with various concentration and time of LPS,
IFN-Q, TNF-K, IL-1L and TGF-L1 (purchased
from Genzyme, Cambridge, MA or from Gibco
BRL, Grand Island, NY) as indicated in the ¢gure
legends. Similarly, the serum-deprived RASMCs
were stimulated with various concentrations (10310^
1038 mol/l) of PDGF, base FGF (bFGF) and EGF
for 0, 1, 3, 6, 14 and 24 h.
2.2. Left common carotid artery balloon angioplasty
Left common carotid artery balloon angioplasty
was performed on male Sprague^Dawley rats as de-
scribed previously [15]. Brie£y, following an anterior
midline incision, the left external carotid artery was
identi¢ed and cleared of adherent tissue, allowing the
insertion of a 2-F Fogarty arterial embolectomy
catheter (Baxter Healthcare, Santa Ana, CA). The
catheter was guided a ¢xed distance (5 cm) down
the common carotid arteries to a point such that
the tip of the catheter was proximal to the aortic
arch where the balloon was in£ated and withdrawn
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back to its point of insertion. This procedure was
performed a total of three times after which the cath-
eter was removed and a suture was tied around the
external carotid artery to prevent exsanguination. Fi-
nally the wound was closed using 9-mm Autoclips
(Clay Adams, Parsippany, NJ). Throughout the sur-
gical procedure, body temperature was maintained at
37 þ 1‡C using a K-20-F water blanket (American
Hamilton, Cincinnati, OH). All surgical interventions
were performed in accordance with the guidelines of
the Animal Care and Use Committee, SmithKline
Beecham and the American Association for Labora-
tory Animal Care.
Left common carotid arteries were isolated from
rats immediately following exsanguination under so-
dium pentobarbital anesthesia (65 mg kg31, i.p.).
Vessels that included the areas devoid of endothe-
lium and containing endothelium were removed
at the following time points: 0 (control), 6 h, 1, 3,
7 and 14 days after surgery. Once isolated, vessels
were immediately frozen in liquid N2 and stored at
370‡C for RNA preparation.
2.3. Isolation of RNA
For RNA preparation, carotid arteries were ho-
mogenized, whereas cultured SMCs were directly
lysed, in an acid guanidinium thiocyanate solution
and extracted with phenol and chloroform as
described previously [12].
2.4. Northern blot analysis
RNA samples extracted from cultured RASMCs
or from carotid artery after balloon angioplasty
were resolved by electrophoresis, transferred onto a
GeneScreen Plus membrane (DuPont^New England
Nuclear, Boston, MA), and subjected for Northern
hybridization as described in detail previously [12].
For Northern analysis, cDNA fragments of rat
MCP-3 [3], MCP-1 [16] and ribosomal protein L32
were isolated from electrophoresis and uniformly la-
beled with [K-32P]dATP (3000 Ci/mmol, Amersham)
using a random-priming DNA labeling kit (Boehr-
inger Mannheim). The rpL32 gene is constantly ex-
pressed in SMCs and in carotid artery after balloon
angioplasty [15] and therefore was used to normalize
the di¡erences of the samples loaded in each lane.
2.5. Reverse transcription and polymerase chain
reaction
For reverse transcription (RT), total cellular RNA
(3 Wg/each sample) isolated from 0, 6 h, 1, 3, 7 and
14 days following carotid artery balloon angioplasty
was reverse transcribed in the presence of 200 U of
RNase H3 SuperScript II reverse transcriptase (Gib-
co BRL) and 1 Wg of oligo(dT)12ÿ18 primer at 37‡C
for 60 min according to manufacturer’s speci¢cation.
The resultant cDNA products were phenol^chloro-
form extracted and ethanol precipitated. The
cDNA pellets were then dried under speed vacuum,
resuspended in 120 Wl of TE (10 mM Tris^HCl and
1 mM EDTA, pH 7.5) and stored at 320‡C until
required for PCR ampli¢cation.
Polymerase chain reaction (PCR) primers for rat
MCP-1 and rpL32 were described previously [12] and
the primers for rat MCP-3 are 5P-CATGGA-
AGTCTGTGCTGAAG-3P and 5P-TGAAACTTCA-
GTAGTCATACA-3P, for the upstream and down-
stream, respectively, corresponding to bases of 295^
314 and 769^789 of the mRNA [3]. For quantitative
purposes, MCP-3 or MCP-1 cDNA was co-ampli¢ed
with rpL32 cDNA, an internal control, and the linear
ampli¢cation was determined as described previously
[12]. The following conditions were chosen as stand-
ard for PCR reactions in a volume of 50 Wl : 100 ng
RNA (for RT), 2.5 units of TaqAmpli polymerase
(Perkin^Elmer Cetus), 30 cycles of ampli¢cation in
the presence of 1U106 cpm (10 ng) labeled antisense
primer for MCP-3 or MCP-1 and 5U104 cpm for
rpL32 antisense primer together with 100 ng of
each non-radioactive sense and antisense primers.
The ampli¢cation was performed using a thermocy-
cler (Perkin^Elmer Cetus) as described previously
[12]. Brie£y, the initial PCR ampli¢cation was per-
formed as follows: denaturation, 3 min at 94‡C; an-
nealing, 1 min at 54‡C; extension, 3 min at 72‡C.
Subsequent cycles of PCR were performed using
the following conditions: denaturation, 15 s at
94‡C; annealing, 20 s at 54‡C; extension, 1 min at
72‡C.
The PCR product (10 Wl each sample) was electro-
phoresed using a 6% polyacrylamide gel. The gel was
dried and subjected to autoradiography at room tem-
perature for overnight. The identity of ampli¢ed
cDNA products was con¢rmed by DNA sequence
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analysis. The relative band intensities were measured
using a PhosphorImager with an ImageQuant soft-
ware package (Molecular Dynamics, Sunnyvale,
CA). The signals of the MCP-3 cDNA were ex-
pressed as the relative ratio to those of rpL32
cDNA in each co-ampli¢ed sample.
2.6. Statistical analysis
Statistical comparisons were made by analysis of
variance (ANOVA; Fisher’s protected least squares
di¡erence) and values were considered to be signi¢-
cant when P6 0.05.
Fig. 1. Northern analysis of time-dependent expression of MCP-3 mRNA in LPS-, IFN-Q-, IL-1L-, TNF-K- and TGF-L1-stimulated
RASMCs. RASMCs were grown to subcon£uence in T-75 £asks, and made quiescent with serum-free medium for 48 h, then stimu-
lated with 200 ng/ml LPS (A), 100 U/ml IFN-Q (B), 1 nM IL-1L (C) and 5 U/ml TNF-K (D) for 0, 0.5, 1, 3, 8 and 24 h for lanes 1,
2, 3, 4, 5 and 6, respectively, or treated with TGF-L1 (E) for 0, 1, 3, 6, 14 and 24 h in order. Total cellular RNA (20 Wg/lane) was re-
solved by electrophoresis, transferred to a nylon membrane, and hybridized to the indicated cDNA probe.
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3. Results
3.1. MCP-3 mRNA expression in cultured RASMCs
in response to LPS, IFN-Q, IL-1L, TNF-K and
TGF-L stimulation
Unstimulated, serum-deprived cultured RASMC
expressed only a very low or undetectable level of
MCP-3 mRNA (Figs. 1 and 2). In the presence of
LPS, IFN-Q, IL-1L, TNF-K and TGF-L, the expres-
sion of MCP-3 mRNA in SMCs was markedly in-
creased in a concentration- and time-dependent man-
ner. Fig. 1 illustrates a representative study of three
independent experiments (n = 3) for the temporal ex-
pression of MCP-3 mRNA in RASMCs stimulated
with LPS, IFN-Q, IL-1L, TNF-K or TGF-L (Fig. 1).
LPS and IL-1L induced a consistent expression of
MCP-3 mRNA and reached a highest level at 24 h
after stimulation, whereas the induced expression of
MCP-3 mRNA by IFN-Q, TNF-K and TGF-L was
decreased at 24 h (Fig. 1). Overall, the expression
pro¢le of MCP-3 mRNA is similar to that of
MCP-1 in these cytokine stimulations, except that
MCP-1 mRNA expression was decreased at 24 h in
LPS and IL-1L treated cells (Fig. 1). Fig. 2 illustrates
a representative blot for MCP-3 mRNA expression
in RASMCs stimulated at low and high concentra-
tion of cytokines for 3 and 8 h. These data also
allowed us to make a direct comparison for the rel-
ative levels of MCP-3 mRNA induction in response
to various stimuli.
3.2. E¡ect of growth factors on MCP-3 mRNA
expression in RASMCs
To determine whether growth factors can a¡ects
MCP-3 mRNA expression in SMCs, cultured
RASMCs were stimulated with various concentra-
tions of PDGF, bFGF and EGF for 30 min^24 h
and evaluated by Northern hybridization. Very low
and inconsistent levels of MCP-3 mRNA expression
was observed (data not shown) in these growth fac-
tor-stimulated RASMCs, while a strong induction
was observed in these samples for positive controls
(c-fos and osteopontin) as demonstrated previously
[15].
Fig. 2. Concentration-dependent induction of MCP-3 mRNA in LPS-, IFN-Q-, IL-1L- and TNF-K-stimulated RASMCs. RASMCs
were deprived of serum for 48 h and stimulated with various stimuli for the indicated concentration for 3 and 8 h, and analyzed by
Northern hybridization.
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3.3. MCP-3 mRNA expression in rat carotid artery
following balloon angioplasty
Since a similar expression pro¢le of MCP-3 and
MCP-1 was observed in RASMCs in response to
cytokine stimulation and induced expression of
MCP-1 mRNA was demonstrated previously follow-
ing balloon angioplasty [12], in the present study we
examined the MCP-3 mRNA expression in rat caro-
tid artery following balloon angioplasty using semi-
quantitative RT^PCR technique (Fig. 3A). The data,
after normalizing to rpL32 mRNA, are depicted in
Fig. 3B. A very low level of MCP-3 mRNA expres-
sion was observed in normal carotid artery. Similar
to MCP-1, maximal MCP-3 mRNA induction was
observed immediately after balloon angioplasty, i.e.,
at 6 h, with 41-fold increase of the mean value over
control, P6 0.001. The signi¢cant induction in
MCP-3 mRNA in carotid artery was observed at
1 day (13-fold increase, P6 0.001) and sustained up
to 3 days (6-fold increase, P6 0.01). The MCP-3
induction after balloon angioplasty was further con-
¢rmed by Northern analysis (Fig. 4). As shown in
Fig. 4, only a very low level of MCP-3 expression
was observed at time 0, but the signal was peaked at
6 h and then diminished at 3 days after balloon in-
jury. This expression pro¢le is strikingly similar to
the PCR data.
4. Discussion
Chemokines are proin£ammatory cytokines that
are traditionally known to play an important role
in leukocyte chemoattraction and activation. Addi-
tional functions of chemokines have recently been
Fig. 3. Time-course study of MCP-3 mRNA expression in rat
carotid artery following balloon angioplasty. Semi-quantitative
RT^PCR was used to analyze the expression of MCP-3 mRNA
in rat carotid artery after balloon angioplasty as described in
detail in Section 2. (A) Representative autoradiographs of the
PCR products (10 Wl/lane) for MCP-3 and MCP-1, respectively,
co-ampli¢ed with rpL32 using the standard conditions. (B)
Quantitative data of MCP-3 mRNA expression in rat carotid
artery following balloon angioplasty. The quantitation was car-
ried out using PhosphorImager analysis, the ratio of MCP-3 to
rpL32 was determined based upon each co-ampli¢ed sample,
and the relative levels (illustrated as the ratios) of MCP-3
mRNA are depicted. Data are presented as the mean þ standard
errors of ¢ve separate samples/experiments and each sample
was pooled from three animals (i.e., 15 animals for each time
point). **P6 0.01, ***P6 0.001, compared to the controls
(time = 0).
Fig. 4. Northern analysis of MCP-3 mRNA expression in rat
carotid artery following balloon angioplasty. Total cellular
RNA was prepared from the pooled samples (10 animals for
each time point at 0, 0.25, 3 and 14 days following angioplasty)
and 10 Wg per lane was resolved by electrophoresis and sub-
jected for Northern analysis as described in Fig. 1. The expo-
sure time for the autoradiograms was 3, 2 and 2 days for the
MCP-3, MCP-1 and rpL32 probes, respectively.
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demonstrated. For example, HIV-1 infection of tar-
get cells has been shown to interact through speci¢c
chemokine receptors such as CCR3 and CCR5 [17].
Recently, chemokines have been implicated in the
pathogenesis of vascular injury including atheroscle-
rosis and restenosis. Several chemokines including
MCP-1, IL-8 and RANTES have been demonstrated
for their induced expression in atherosclerotic vessels
[6,7,18,19]. Some chemokines such as MCP-1 and IP-
10 are upregulated in neointimal formation [12,20].
On the other hand, functional chemokine receptors
have been identi¢ed on cell surfaces of T lympho-
cytes and monocytes [5], as well as on vascular
SMCs [13]. In particular, the absence of CCR2 (the
receptor for MCP-1 and -3) was found to be critical
in the development of atherosclerotic lesions [8], sug-
gesting that its corresponding ligands are likely par-
ticipating vascular diseases/injuries.
MCP-3 is known to share some key biological fea-
tures with MCP-1; however, its expression and po-
tential function in SMCs and vascular pathology
have not been explored. To investigate the potential
role of MCP-3 in vascular injury, the present study
examined the expression of MCP-3 mRNA in vascu-
lar SMCs in response to various in£ammatory medi-
ators that are involved in vascular disease process
[9,10,14]. Our data demonstrated that MCP-3
mRNA expression can be markedly induced in
SMCs by these in£ammatory cytokines and in the
carotid artery after balloon angioplasty. The expres-
sion pro¢le of MCP-3 under these conditions paral-
lels to that of MCP-1, suggesting that both CC che-
mokines may play an important role in vascular
injury such as atherosclerosis and restenosis. While
both chemokines induced in these experimental con-
ditions, they may play distinct roles in vascular in-
jury since they have unique preferences to chemokine
receptors, i.e., both chemokines react to CCR2 but
only MCP-3 for CCR3. In addition, the di¡erent
time-course expression was observed for MCP-1
and MCP-3 in SMCs in response to LPS and IL-1L
stimulation (Fig. 1). Previous studies revealed a sim-
ilar but distinct expression pro¢le of these two cyto-
kines in monocytes, with a more restricted cellular
expression for MCP-3. For example, MCP-1 is
highly expressed in ¢broblasts in response to IL-1
and TNF stimulation but MCP-3 only at very low
level [1].
The time-course studies revealed that MCP-3
mRNA expression in carotid artery after balloon
angioplasty represents a ¢rst wave of injury response
(0^3 days), with the characteristic of medial SMCs
proliferation [10]. At this early time point, FGF,
PDGF, TGF-L and angiotensin II are thought to
play an important role. Similar temporal expression
¢le was observed for MCP-1 mRNA after balloon
angioplasty in rat [12,21]. While the exact biological
function of MCP-3 and MCP-1 induction following
vascular injury remains to be further investigated,
recent data using neutralizing antibodies against
MCP-1 suggest that MCP-1 may contribute to the
accumulation of macrophages and the early increase
of vascular SMCs in the intima after balloon angio-
plasty [21]. These data are in agreement with the
previous localization and potential role of mono-
cytes/macrophages in the vascular tissue after bal-
loon angioplasty [22,23] in addition to the fact that
SMC proliferation and migration are classically
thought to be the major cellular response for reste-
nosis. The induced expression of MCP-3 mRNA
after vascular injury suggests that this chemokine
may play a similar role in macrophage accumulation
and SMC activation in the injured vascular tissue. It
also should be pointed out that the possibility of the
increased levels of MCP-3 mRNA to be translated
into active protein after balloon injury remains to be
demonstrated. It is also important to de¢ne the cel-
lular sources of MCP-3 after vascular injury in order
to elucidate the role of MCP-3 following balloon
angioplasty.
In summary, the present study demonstrated
MCP-3 mRNA expression in vascular SMCs in re-
sponse to in£ammatory cytokines and in carotid ar-
tery after balloon angioplasty, suggesting that MCP-
3, in addition to MCP-1, may play an active role in
the accumulation of monocytes/macrophages and in
the SMC activation after vascular injury. Further
studies remain to be carried out in order to validate
the exact role of this chemokine in the neointima
formation.
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